Skip to main content
7221 search results for:

Sunitinib 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Sunitinib | News

    Sunitinib

    Leucopenia and mouth ulcers
  2. 01-04-2024 | Sunitinib | News

    Sunitinib

    Lack of efficacy
  3. 01-04-2024 | Sunitinib | News

    Sunitinib

    Lack of efficacy
  4. 01-04-2024 | Hemorrhoids | News

    Sunitinib

    Hemorrhagic shock and haemorrhoids
  5. 01-04-2024 | Sunitinib | News

    Sunitinib

    Lack of efficacy
  6. 23-02-2024 | Sunitinib | Online First

    Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma

    Renal cell carcinoma (RCC) is the most common malignant tumor of kidney. Of those, clear cell carcinoma is the mainly pathological subtype, accounting for 70~75% of RCC [ 1 ]. There are 20~30% of RCC patients present metastatic stage at the primary …

  7. Open Access 01-12-2024 | Kidney Cancer | OriginalPaper

    Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification

    Glycolysis-related metabolic reprogramming is a central hallmark of human cancers, especially in renal cell carcinoma. However, the regulatory function of glycolytic signature in papillary RCC has not been well elucidated. In the present study …

  8. 28-02-2024 | Neuroendocrine Tumor | News | Article

    Sunitinib shows promise for ultra-rare neuroendocrine tumors

    The randomized FIRSTMAPPP study supports the use of sunitinib for treating patients with metastatic progressive pheochromocytomas and paragangliomas.

  9. 01-02-2024 | Sunitinib | News

    Sunitinib

    Various toxicities
  10. 01-02-2024 | Sunitinib | News

    Sunitinib: risk of retinal detachment

  11. Open Access 01-12-2024 | OriginalPaper

    Interaction between Wnt/β-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma

    Renal cell carcinoma (RCC) is one of the most common malignant tumours of the urinary system, and its mortality ranks sixth in male tumours and eighth in female tumours [ 1 , 2 ] . Due to the poor prognosis of early-stage RCC and resistance to both …

  12. Open Access 01-12-2023 | Kidney Cancer | OriginalPaper

    Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study

  13. 01-12-2023 | Thrombotic Microangiopathy | News

    Sunitinib

    Renal thrombotic microangiopathy
  14. 01-10-2023 | Sunitinib | News

    Sunitinib

    Thrombotic microangiopathy, cerebral infarction and hypertension: 2 case reports
  15. 01-05-2023 | Losartan | News

    Sunitinib

    Various toxicities: case report
  16. 01-09-2023 | Sunitinib | News

    Sunitinib/Nivolumab

    Malaise, nausea and skin toxicity: case report
  17. 10-11-2023 | Sunitinib | Online First

    CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors

    Gastrointestinal stromal tumors (GISTs) can be treated with sunitinib malate as a second-line multitargeted receptor tyrosine kinase inhibitor (TKI) when patients are refractory to imatinib [ 1 , 2 ]. However, it was reported that approximately 19% …

  18. Open Access 01-12-2022 | Kidney Cancer | OriginalPaper

    Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study

    In the past two decades, over 40 tyrosine kinase inhibitors (TKIs) have been developed and approved for the treatment of many cancer types [ 1 ]. The majority of these drugs target the receptor-linked tyrosine kinases for growth factors, e.g. …

  19. 01-09-2023 | Sunitinib | News

    Sunitinib/zoledronic-acid

    Osteonecrosis of the jaw and lack of efficacy: case report
  20. 01-08-2023 | Sunitinib | News

    Sunitinib

    Cardiomyopathy following off-label use: case report

Filter search results

Journal article

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.